Okwan-Duodu, D., Datta, V., Shen, X.Z., Goodridge, H.S., Bernstein, E.A., Fuchs, S., Liu, G.Y., and Bernstein, K.E.: Angiotensin-converting enzyme overexpression in mouse myelomonocytic cells augments resistance to Listeria and methicillin-resistant Staphylococcus aureus. J. Biol. Chem. 2010, 285:39051–39060.
Ridker, P.M., Cannon, C.P., Morrow, D., Rifai, N., Rose, L.M., McCabe, C.H., Pfeffer, M.A., Braunwald, E: Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators: C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 2005, 352:20–28.
Youssef, S., Stuve, O., Patarroyo, J.C., Ruiz, P.J., Radosevich, J.L., Hur, E.M., Bravo, M., Mitchell, D.J., Sobel, R.A., Steinman, L., et al.: The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 2002, 420:78–84.
16-12 Controlled administration of antigen can be used to manipulate the nature of an antigen-specific response.
Diabetes Prevention Trial: Type 1 Diabetes Study Group: Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 2002, 346:1685–1691.
Haselden, B.M., Kay, A.B., and Larché, M.: Peptide-mediated immune responses in specific immunotherapy. Int. Arch. Allergy. Immunol. 2000, 122:229–237.
Mowat, A.M., Parker, L.A., Beacock-Sharp, H., Millington, O.R., and Chirdo, F.: Oral tolerance: overview and historical perspectives. Ann. N.Y. Acad. Sci. 2004, 1029:1–8.
Steinman, L., Utz, P.J., and Robinson, W.H.: Suppression of autoimmunity via microbial mimics of altered peptide ligands. Curr. Top. Microbiol. Immunol. 2005, 296:55–63.
Weiner, H.L., da Cunha, A.P., Quintana, F., and Wu, H.: Oral tolerance. Immunol. Rev. 2011, 241:241–259.
16-13 The development of transplantable tumors in mice led to the discovery of protective immune responses to tumors.
Jaffee, E.M., and Pardoll, D.M.: Murine tumor antigens: is it worth the search? Curr. Opin. Immunol. 1996, 8:622–627.
Klein, G.: The strange road to the tumor-specific transplantation antigens (TSTAs). Cancer Immun. 2001, 1:6.
16-14 Tumors are ‘edited’ by the immune system as they evolve and can escape rejection in many ways.
Dunn, G.P., Old, L.J., and Schreiber, R.D.: The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004, 21:137–148.